NCT07276685

Brief Summary

This randomized clinical study aimed to compare the clinical and radiographic outcomes of TheraCal PT and Biodentine in pulpotomy treatment of primary teeth and to evaluate the influence of low-level laser therapy (LLLT) on treatment outcomes in pediatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 18, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
Last Updated

December 11, 2025

Status Verified

November 1, 2025

Enrollment Period

2.5 years

First QC Date

November 18, 2025

Last Update Submit

November 28, 2025

Conditions

Keywords

Primary ToothPulpotomyTheraCal PTBiodentineLow-Level Laser Therapy

Outcome Measures

Primary Outcomes (1)

  • Clinical and Radiographic Success Rate of Pulpotomy Treatments in Primary Molars

    Number of teeth with clinical success defined as absence of spontaneous pain, swelling, sinus tract, pathological mobility, or tenderness to percussion, and number of teeth with radiographic success defined as absence of internal or external root resorption and absence of furcal or periapical radiolucency. Results will be reported as number and percentage of successful teeth.

    12 months after treatment

Secondary Outcomes (2)

  • Interim Clinical and Radiographic Success Rates

    3 and 6 months after treatment

  • Effect of Low-Level Laser Therapy (LLLT) on Pulpotomy Success

    12 months after treatment

Study Arms (4)

Biodentine

ACTIVE COMPARATOR

Primary molars treated with pulpotomy using Biodentine without low-level laser therapy (LLLT). After coronal pulp removal, Biodentine (Septodont, France) was placed over the remaining pulp tissue. No laser application was performed.

Procedure: Biodentine Pulpotomy

LLLT + Biodentine

EXPERIMENTAL

Primary molars treated with Biodentine pulpotomy combined with low-level laser therapy. After pulpotomy, diode laser (940 nm, 10 s, non-contact mode) was applied over the pulp chamber floor, followed by placement of Biodentine (Septodont, France).

Device: Low-Level Laser Therapy + Biodentine

TheraCal PT

EXPERIMENTAL

Primary molars treated with pulpotomy using TheraCal PT without low-level laser therapy. After coronal pulp removal, TheraCal PT (Bisco Inc., USA) was applied directly onto the pulp tissue. No laser application was performed.

Procedure: TheraCal PT Pulpotomy

LLLT + TheraCal PT

EXPERIMENTAL

Primary molars treated with TheraCal PT pulpotomy combined with low-level laser therapy. Following pulpotomy, a 940 nm diode laser (Biolase, USA) was applied for 10 seconds in non-contact mode, followed by application of TheraCal PT (Bisco Inc., USA).

Device: Low-Level Laser Therapy + TheraCal PT

Interventions

After coronal pulp removal, Biodentine (Septodont, France) was placed over the remaining pulp tissue. No laser application was performed.

Also known as: biomaterial
Biodentine

After pulpotomy, diode laser (940 nm, 10 s, non-contact mode) was applied over the pulp chamber floor, followed by placement of Biodentine (Septodont, France).

Also known as: Laser and biomaterial
LLLT + Biodentine

After coronal pulp removal, TheraCal PT (Bisco Inc., USA) was applied directly onto the pulp tissue. No laser application was performed.

TheraCal PT

Following pulpotomy, a 940 nm diode laser (Biolase, USA) was applied for 10 seconds in non-contact mode, followed by application of TheraCal PT (Bisco Inc., USA).

LLLT + TheraCal PT

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy children aged between 6 and 9 years. Primary molars with carious exposures requiring pulpotomy treatment. Teeth with vital pulp confirmed by the absence of spontaneous pain and the presence of normal bleeding after coronal pulp removal.
  • Teeth with restorable crowns suitable for stainless steel crown restoration. Cooperative patients who can attend all follow-up appointments.

You may not qualify if:

  • Teeth with signs of irreversible pulpitis or necrosis (e.g., spontaneous or nocturnal pain).
  • Teeth with internal or external root resorption, furcal or periapical radiolucency.
  • Non-restorable teeth or those with excessive loss of crown structure. Patients with systemic diseases or on long-term medication that could affect healing.
  • Uncooperative children or those lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpasa University Faculty of Dentistry

Tokat Province, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Biocompatible MaterialsLow-Level Light TherapyLasers

Intervention Hierarchy (Ancestors)

Biomedical and Dental MaterialsSpecialty Uses of ChemicalsChemical Actions and UsesManufactured MaterialsTechnology, Industry, and AgricultureLaser TherapyTherapeuticsPhototherapyOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Necibe Damla ŞAHİN, DDS, PhD

    Tokat Gaziosmanpaşa University, Faculty of Dentistry, Department of Pediatric Dentistry, Tokat, Turkey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was blinded to the treatment groups during clinical and radiographic evaluations. Participants and operators were not blinded due to the nature of the interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study was designed as a parallel-group randomized clinical trial. Sixty primary molars from children aged 4-9 years were randomly assigned to four intervention groups according to the material used (Biodentine or TheraCal PT) and the use of low-level laser therapy (LLLT).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 11, 2025

Study Start

January 5, 2023

Primary Completion

July 5, 2025

Study Completion

October 15, 2025

Last Updated

December 11, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because this study involved pediatric participants and the data contain potentially identifiable information. Only summary data will be available in the published article.

Locations